Go Pro
NASDAQ:JMAC

Maxpro Capital Acquisition (JMAC) Stock Price, News & Analysis

Maxpro Capital Acquisition logo
$19.56 -0.60 (-2.98%)
As of 07/2/2026

About Maxpro Capital Acquisition Stock (NASDAQ:JMAC)

Advanced

Key Stats

Today's Range
$18.25
$19.75
50-Day Range
$12.85
$22.83
52-Week Range
$7.50
$19.22
Volume
14,803 shs
Average Volume
74,040 shs
Market Capitalization
$262.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive JMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maxpro Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JMAC Stock News Headlines

Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
Maxpro Capital Acquisition Corp
See More Headlines

JMAC Stock Analysis - Frequently Asked Questions

Maxpro Capital Acquisition's stock was trading at $18.6950 at the beginning of the year. Since then, JMAC shares have increased by 4.6% and is now trading at $19.56.

Shares of JMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Maxpro Capital Acquisition investors own include Meta Platforms (META), Dermata Therapeutics (DRMA), Daifuku (DAIUF), CXApp (CXAI),

Company Calendar

Today
7/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Holding & other investment offices
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:JMAC
CIK
1874259
Web
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
13,428,000
Free Float
10,840,000
Market Cap
$262.65 million
Optionable
Not Optionable
Beta
0.01

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:JMAC) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners